BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Semantic Scholar
Computational modelling of potent β-secretase (BACE1) inhibitors towards Alzheimer's disease treatment - ScienceDirect
Alzheimer's Disease Insight Report: Current Therapies, Drug Pipeline and Outlook
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease | Nature Reviews Neurology
Frontiers | Targeting Amyloidogenic Processing of APP in Alzheimer's Disease | Molecular Neuroscience
IJMS | Free Full-Text | Natural Products Targeting Amyloid Beta in Alzheimer's Disease | HTML
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Semantic Scholar
Critical analysis of the use of β-site amyloid precursor protein- | DNND
PDF) BACE1 inhibitor drugs in clinical trials for Alzheimer's disease
Small molecule BACE1 inhibitors in clinical trials | Download Table
Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease* - Journal of Biological Chemistry
The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease | EMBO Molecular Medicine
Current status of anti-Alzheimer's disease drugs in trials | Download Scientific Diagram
Pharmaceuticals | Free Full-Text | BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease | HTML
Alzheimer's disease: clinical trials and drug development - The Lancet Neurology
Medicinal Chemistry in Review: BACE1 Inhibitors as a Treatment for Alzheimer's Disease | Domainex
A Perspective on Multi-target Drugs for Alzheimer's Disease: Trends in Pharmacological Sciences
The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Targeting the β secretase BACE1 for Alzheimer's disease therapy - The Lancet Neurology
Aβ34 is a BACE1-derived degradation intermediate associated with amyloid clearance and Alzheimer's disease progression | Nature Communications
Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein - ScienceDirect
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Semantic Scholar
BACE1 Inhibitors in Phase 3 Trials for Alzheimer's are Safe in Moderate Doses, According to Study - Alzheimer's News Today
BACE1 inhibitor drugs in clinical trials for Alzheimer's disease | Semantic Scholar
Frontiers | Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment | Chemistry
